Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer.
Saved in:
| Title: | Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer. |
|---|---|
| Authors: | Xu X; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Sun XY; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Chang M; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Hu ZL; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Cheng TT; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Hang TJ; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China., Song M; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China. |
| Source: | Pharmaceutical biology [Pharm Biol] 2023 Dec; Vol. 61 (1), pp. 1298-1309. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print Cited Medium: Internet ISSN: 1744-5116 (Electronic) Linking ISSN: 13880209 NLM ISO Abbreviation: Pharm Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37606265 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xu+X%22">Xu X</searchLink>; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Sun+XY%22">Sun XY</searchLink>; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Chang+M%22">Chang M</searchLink>; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Hu+ZL%22">Hu ZL</searchLink>; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Cheng+TT%22">Cheng TT</searchLink>; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Hang+TJ%22">Hang TJ</searchLink>; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Song+M%22">Song M</searchLink>; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229812552%22">Pharmaceutical biology</searchLink> [Pharm Biol] 2023 Dec; Vol. 61 (1), pp. 1298-1309. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9812552 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-5116 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213880209%22">13880209 </searchLink><i>NLM ISO Abbreviation: </i>Pharm Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37606265 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/13880209.2023.2246500 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1298 Titles: – TitleFull: Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xu X – PersonEntity: Name: NameFull: Sun XY – PersonEntity: Name: NameFull: Chang M – PersonEntity: Name: NameFull: Hu ZL – PersonEntity: Name: NameFull: Cheng TT – PersonEntity: Name: NameFull: Hang TJ – PersonEntity: Name: NameFull: Song M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2023 Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1744-5116 Numbering: – Type: volume Value: 61 – Type: issue Value: 1 Titles: – TitleFull: Pharmaceutical biology Type: main |
| ResultId | 1 |